Litcius/Paper detail

Off-label use of aducanumab for cerebral amyloid angiopathy

Steven M. Greenberg, Charlotte Cordonnier, Julie A. Schneider, Eric E. Smith, Mark A. van Buchem, Susanne J. van Veluw, Marcel M. Verbeek, Anand Viswanathan, David J. Werring

2021The Lancet Neurology30 citationsDOIOpen Access PDF

Topics & Concepts

Cerebral amyloid angiopathyMedicineFood and drug administrationSuperficial siderosisIntracerebral hemorrhageDiseaseAlzheimer's diseaseIntensive care medicinePathologyInternal medicinePharmacologyDementiaSubarachnoid hemorrhageIntracerebral and Subarachnoid Hemorrhage ResearchAlzheimer's disease research and treatmentsCerebrovascular and genetic disorders
Off-label use of aducanumab for cerebral amyloid angiopathy | Litcius